GlassScriptPrepare for your visit
Atif Ben Collins
Ophthalmic Plastic and Reconstructive Surgery · Fresno, CA · NPI 1891010948
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$3,775.11
in general payments reported to CMS, 2019-2025 · $3,068 in 2025
The $3,068 reported for 2025 was more than what 84% of Ophthalmic Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $299).
Who reported paying
General payments only, top 6 by amount.
- Genentech, INC. $2,902.84
- Amgen INC. $434.37
- Abbvie INC. $163.43
- Horizon Therapeutics Plc $161.64
- Bausch & Lomb, A Division of Bausch Health US, LLC $61.82
- Galderma Laboratories, L.P. $51.01
Drugs and devices associated with these payments
Actemra Cellcept Enspryng Tepezza Botox Dysport
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Atif Collins listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/559153/atif-ben-collins